Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 660

Similar articles for PubMed (Select 12409719)

1.

Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases.

Pelmus M, Guillou L, Hostein I, Sierankowski G, Lussan C, Coindre JM.

Am J Surg Pathol. 2002 Nov;26(11):1434-40.

PMID:
12409719
2.

Tissue microarray profiling of primary and xenotransplanted synovial sarcomas demonstrates the immunophenotypic similarities existing between SYT-SSX fusion gene confirmed, biphasic, and monophasic fibrous variants.

Subramaniam MM, Navarro S, Pellin A, López-Guerrero JA, Carda C, Heredia Alvaro JA, Gozalbo Sabater PL, Llombart-Bosch A.

Virchows Arch. 2006 Oct;449(4):435-47. Epub 2006 Sep 7.

PMID:
16957934
3.

Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.

Antonescu CR, Kawai A, Leung DH, Lonardo F, Woodruff JM, Healey JH, Ladanyi M.

Diagn Mol Pathol. 2000 Mar;9(1):1-8.

PMID:
10718206
4.

Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.

Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Kawai A, Sonobe H, Takahira T, Kobayashi C, Yamamoto H, Tamiya S, Hirohashi S, Iwamoto Y, Tsuneyoshi M.

Am J Surg Pathol. 2007 Jan;31(1):85-94.

PMID:
17197923
5.

Detection of the synovial sarcoma translocation t(X;18) (SYT;SSX) in paraffin-embedded tissues using reverse transcriptase-polymerase chain reaction: a reliable and powerful diagnostic tool for pathologists. A molecular analysis of 221 mesenchymal tumors fixed in different fixatives.

Guillou L, Coindre J, Gallagher G, Terrier P, Gebhard S, de Saint Aubain Somerhausen N, Michels J, Jundt G, Vince DR, Collin F, Trassard M, Le Doussal V, Benhattar J.

Hum Pathol. 2001 Jan;32(1):105-12.

PMID:
11172303
6.

Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.

Amary MF, Berisha F, Bernardi Fdel C, Herbert A, James M, Reis-Filho JS, Fisher C, Nicholson AG, Tirabosco R, Diss TC, Flanagan AM.

Mod Pathol. 2007 Apr;20(4):482-96. Epub 2007 Mar 2.

7.

Primary intrathoracic synovial sarcoma: a clinicopathologic study of 40 t(X;18)-positive cases from the French Sarcoma Group and the Mesopath Group.

Bégueret H, Galateau-Salle F, Guillou L, Chetaille B, Brambilla E, Vignaud JM, Terrier P, Groussard O, Coindre JM.

Am J Surg Pathol. 2005 Mar;29(3):339-46.

PMID:
15725802
8.

Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases.

Coindre JM, Pelmus M, Hostein I, Lussan C, Bui BN, Guillou L.

Cancer. 2003 Dec 15;98(12):2700-7.

9.

Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma.

van de Rijn M, Barr FG, Collins MH, Xiong QB, Fisher C.

Am J Clin Pathol. 1999 Jul;112(1):43-9.

PMID:
10396284
10.

Primary synovial sarcoma of the prostate: report of 2 cases and literature review.

Jun L, Ke S, Zhaoming W, Linjie X, Xinru Y.

Int J Surg Pathol. 2008 Jul;16(3):329-34. doi: 10.1177/1066896907309575. Epub 2008 Apr 2.

PMID:
18387992
11.

Molecular diagnosis of synovial sarcoma: RT-PCR detection of SYT-SSX1/2 fusion transcripts in paraffin-embedded tissue.

Tvrdík D, Povýsil C, Svatosová J, Dundr P.

Med Sci Monit. 2005 Mar;11(3):MT1-7.

PMID:
15735574
12.

SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.

Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M.

N Engl J Med. 1998 Jan 15;338(3):153-60.

13.

Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.

Jagdis A, Rubin BP, Tubbs RR, Pacheco M, Nielsen TO.

Am J Surg Pathol. 2009 Dec;33(12):1743-51. doi: 10.1097/PAS.0b013e3181b7ed36.

PMID:
19809272
14.

[Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].

Sun Y, Sun BC, Zhao XL, Wang J, Chen J, Li XQ, Feng YM, Fang ZW, Hao XS.

Zhonghua Bing Li Xue Za Zhi. 2007 Jul;36(7):480-4. Chinese.

PMID:
17845763
15.

Poorly differentiated synovial sarcoma: an analysis of clinical, pathologic, and molecular genetic features.

van de Rijn M, Barr FG, Xiong QB, Hedges M, Shipley J, Fisher C.

Am J Surg Pathol. 1999 Jan;23(1):106-12.

PMID:
9888710
16.

Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.

Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldsmith JD, Brooks JS, Goldblum JR, Ali SZ, Shipley J, Cooper CS, Fisher C, Skytting B, Larsson O.

Cancer Res. 2002 Jan 1;62(1):135-40.

17.

Detection of SYT-SSX fusion transcripts in archival synovial sarcomas by real-time reverse transcriptase-polymerase chain reaction.

Bijwaard KE, Fetsch JF, Przygodzki R, Taubenberger JK, Lichy JH.

J Mol Diagn. 2002 Feb;4(1):59-64.

18.

Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma.

Mancuso T, Mezzelani A, Riva C, Fabbri A, Dal Bo L, Sampietro G, Perego P, Casali P, Zunino F, Sozzi G, Pierotti MA, Pilotti S.

Lab Invest. 2000 Jun;80(6):805-13.

PMID:
10879732
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk